Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1
- PMID: 15452240
- PMCID: PMC521858
- DOI: 10.1128/JVI.78.20.11208-11218.2004
Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1
Abstract
Human immunodeficiency virus type 1 (HIV-1) exists as a complex population of multiple genotypic variants in persons with chronic infection. However, acute HIV-1 infection via sexual transmission is a low-probability event in which there is thought to be low genetic complexity in the initial inoculum. In order to assess the viral complexity present during primary HIV-1 infection, the V1/V2 and V3 variable regions of the env gene were examined by using a heteroduplex tracking assay (HTA) capable of resolving these genotypic variants. Blood plasma samples from 26 primary HIV-1-infected subjects were analyzed for their level of diversity. Half of the subjects had more than one V1/V2 viral variant during primary infection, indicating the frequent transmission of multiple variants. This observation is inconsistent with the idea of infrequent transmission based on a small transmitting inoculum of cell-free virus. In chronically infected subjects, the complexity of the viral populations was even greater in both the V1/V2 and the V3 regions than in acutely infected subjects, indicating that in spite of the presence of multiple variants in acute infection, the virus does pass through a genetic bottleneck during transmission. We also examined how well the infecting virus penetrated different anatomical compartments by using the HTA. Viral variants detected in blood plasma were compared to those detected in seminal plasma and/or cerebral spinal fluid of six individuals. The virus in each of these compartments was to a large extent identical to virus in blood plasma, a finding consistent with rapid penetration of the infecting variant(s). The low-probability transmission of multiple variants could be the result of transient periods of hyperinfectiousness or hypersusceptibility. Alternatively, the inefficient transfer of a multiply infected cell could account for both the low probability of transmission and the transfer of multiple variants.
Figures









Similar articles
-
Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection.J Virol. 2003 Jun;77(12):6811-22. doi: 10.1128/jvi.77.12.6811-6822.2003. J Virol. 2003. PMID: 12768001 Free PMC article.
-
Independent evolution of human immunodeficiency virus type 1 env V1/V2 and V4/V5 hypervariable regions during chronic infection.J Virol. 2007 May;81(10):5413-7. doi: 10.1128/JVI.02554-06. Epub 2007 Feb 28. J Virol. 2007. PMID: 17329337 Free PMC article.
-
Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.AIDS. 2003 Sep 26;17(14):2025-33. doi: 10.1097/00002030-200309260-00003. AIDS. 2003. PMID: 14502005
-
Analysis of human immunodeficiency virus type 1 env and gag sequence variants derived from a mother and two vertically infected children provides evidence for the transmission of multiple sequence variants.J Gen Virol. 1998 May;79 ( Pt 5):1055-68. doi: 10.1099/0022-1317-79-5-1055. J Gen Virol. 1998. PMID: 9603320
-
Using HIV-1 sequence variability to explore virus biology.Virus Res. 2001 Aug;76(2):137-60. doi: 10.1016/s0168-1702(01)00271-4. Virus Res. 2001. PMID: 11410314 Review.
Cited by
-
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections.PLoS Pathog. 2011 Sep;7(9):e1002209. doi: 10.1371/journal.ppat.1002209. Epub 2011 Sep 29. PLoS Pathog. 2011. PMID: 21980282 Free PMC article. Clinical Trial.
-
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18514-9. doi: 10.1073/pnas.0504658102. Epub 2005 Dec 9. Proc Natl Acad Sci U S A. 2005. PMID: 16339909 Free PMC article.
-
Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma viruses.Retrovirology. 2008 Feb 29;5:23. doi: 10.1186/1742-4690-5-23. Retrovirology. 2008. PMID: 18312646 Free PMC article.
-
Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.J Virol. 2005 Jul;79(13):7959-66. doi: 10.1128/JVI.79.13.7959-7966.2005. J Virol. 2005. PMID: 15956542 Free PMC article.
-
Compartmentalization and Clonal Amplification of HIV-1 in the Male Genital Tract Characterized Using Next-Generation Sequencing.J Virol. 2020 Jun 1;94(12):e00229-20. doi: 10.1128/JVI.00229-20. Print 2020 Jun 1. J Virol. 2020. PMID: 32269124 Free PMC article.
References
-
- Betts, M. R., J. Krowka, C. Santamaria, K. Balsamo, F. Gao, G. Mulundu, C. Luo, N. N′Gandu, H. Sheppard, B. H. Hahn, S. Allen, and J. A. Frelinger. 1997. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J. Virol. 71:8908-8911. - PMC - PubMed
-
- Borrow, P., H. Lewicki, X. Wei, M. S. Horwitz, N. Peffer, H. Meyers, J. A. Nelson, J. E. Gairin, B. H. Hahn, M. B. Oldstone, and G. M. Shaw. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211. - PubMed
-
- Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208. - PubMed
-
- Chakraborty, H., P. K. Sen, R. W. Helms, P. L. Vernazza, S. A. Fiscus, J. J. Eron, B. K. Patterson, R. W. Coombs, J. N. Krieger, and M. S. Cohen. 2001. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 15:621-627. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
- T32 AI 007419/AI/NIAID NIH HHS/United States
- M01 RR000046/RR/NCRR NIH HHS/United States
- K23 AI 01781/AI/NIAID NIH HHS/United States
- T32 AI007419/AI/NIAID NIH HHS/United States
- RR 00046/RR/NCRR NIH HHS/United States
- K24 AI001608/AI/NIAID NIH HHS/United States
- R01 DK049381/DK/NIDDK NIH HHS/United States
- K23 AI001781/AI/NIAID NIH HHS/United States
- R01 DK 49381/DK/NIDDK NIH HHS/United States
- R01 AI044667/AI/NIAID NIH HHS/United States
- P30 AI 50410/AI/NIAID NIH HHS/United States
- R01 AI 44667/AI/NIAID NIH HHS/United States
- K24 AI 01608/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases